Drug
Gestodene clinical trials
- studies test it
- 13
- open now
- 0
- in phase 3
- 3
- first study started
- 2008
How studies write it
Studies that test it under each name
Studies by the year they started
13 studies that test it; most in 2009 (7)
| Year | Studies |
|---|---|
| 2008 | 2 |
| 2009 | 7 |
| 2010 | 1 |
| 2015 | 1 |
| 2016 | 1 |
| 2017 | 1 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 2
- Phase 2
- 7
- Phase 3
- 3
- Phase 4
- 2
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 10 · Other 3
Bayer (10) · Hospital Geral de Fortaleza (1) · Mahidol University (1) · Ain Shams University (1)
Often tested with
Tested in the same studies.
Ethinyl Estradiol (13) · Estradiol (1) · Nomegestrol acetate (1) · Megestrol (1)
Studies
Open first, then newest update. How each study uses Gestodene is read from its arms, and is right about nine times in ten.
Testing it · 13
- Study Investigating the Efficacy and Safety of a Contraceptive Patch for 13 CyclesCompletedPhase 3BayerNCT00910637Written as Gestodene/EE Patch (BAY86-5016)
- US Ovulation Inhibition Study in Obese WomenCompletedPhase 2BayerNCT00873483Written as Ethinylestradiol/Gestodene (BAY86-5016)
- OCP Pretreatment in PCOS Patients Undergoing ICSI Using Antagonist ProtocolStatus unknownPhase 1/2Ain Shams UniversityNCT03881904Written as 0.075mg gestodene/0.03mg ethinylestradiol
- Comparison of Coagulation Profiles Between Zoely and Minidoz: RCTTerminatedPhase 4Mahidol UniversityNCT03531437Written as 15 µg ethinylestradiol and 60 µg gestodene
- Russia/Ukraine Suppression of Ovarian Activity StudyCompletedPhase 2BayerNCT02550977Written as Gestodene/EE Patch (BAY86-5016)
- EU/LA Pearl Index Study - Transdermal Contraceptive PatchCompletedPhase 3BayerNCT00914693Written as Ethinylestradiol/Gestodene (BAY86-5016)
- Inhibition of Ovulation, Patch, Ethinylestradiol and GestodeneTerminatedPhase 2BayerNCT00729404Written as Ethinylestradiol/Gestodene (BAY86-5016)
- FC Patch Low: Metabolism StudyCompletedPhase 2BayerNCT00933179Written as Gestodene/EE Patch (BAY86-5016)
- Investigation of Three Contraceptive Hormone Patches in Regard to Inhibition of Ovulation Following Application Over 3 Treatment Cycles in Healthy, Young Women.CompletedPhase 2BayerNCT01204190Written as Gestodene/EE Patch (BAY86-5016)
- Inhibition of Ovulation and Pharmacokinetics of Transdermal Ethinylestradiol (EE) and Gestodene (GSD)CompletedPhase 2BayerNCT00915915Written as Ethinylestradiol/Gestodene (BAY86-5016)
- Relative Bioavailability, Transdermally Administered EE and GSD, 3 Applications SitesCompletedPhase 1BayerNCT01083264Written as Gestodene/EE Patch (BAY86-5016)
- Birth Control Patch StudyCompletedPhase 3BayerNCT00984789Written as Ethinylestradiol/Gestodene (FC Patch Low BAY86-5016)
- Improvement of Quality of Life in Patients Using Low-dose Pills in the Different Phases of MenacmeCompletedPhase 4Hospital Geral de FortalezaNCT01174524Written as gestoden 60 mcg
Codes
What other systems call Gestodene · ClinicalTrials.gg INT003000
- MeSH (NLM) C033273GestodeneConfirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) 1664P6E6MIGESTODENEConfirmed FDA, NLM, Wikidata
- RxNorm 25734Confirmed FDA, Wikidata
- Wikidata Q408289gestodeneConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C87240GestodeneOne source FDA
- DrugBank DB06730One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C033273 | Gestodene | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | 1664P6E6MI | GESTODENE | Confirmed FDA, NLM, Wikidata |
| RxNorm | 25734 | — | Confirmed FDA, Wikidata |
| Wikidata | Q408289 | gestodene | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C87240 | Gestodene | One source FDA |
| DrugBank | DB06730 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.